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dye injection into the tumor. Sentinel nodes stained bright blue and were removed. The sentinel 
nodes have been examined under the microscope for cancer signs. Depending on the biopsy 
results this was followed or not by lymphadenectomy . Parameters like age, size of tumor, 
Nottingham grade, presence of hormonal receptors, HER 2 enriche, presence of 
microcalcification, necrosis and inflammatory infiltrate have been studied to predict the risk of 
axillary metastasis.  
Results. Forty patients received SLN biopsy after neoadjuvant chemotherapy. Ten cases (25%) 
of these had positive sentinel lymph nodes confirmed by anatomopathological examination. 
Lymphadenectomy procedure have been performed and only 3 of them (30%) had metastatic 
lymph nodes in the rest of the axilla.  
Conclusions. SLN biopsy accuracy after neoadjuvant chemotherapy is still debated in 
literature. Thirty of our patients were saved form an unnecessary axillary lymph node 
dissection by using SLN biopsy technique.  
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Introduction. Exocrine pancreatic insufficiency is frequently associated with diabetes, with 
high prevalence in both insulin-dependent or insulin-independent patients. Historically, 
diabetes due to diseases of the exocrine pancreas was described as pancreatogenic diabetes 
mellitus, but recent literature refers to it as type 3c diabetes as it was classified by American 
Diabetes Association.   
Aim of the study. De-novo diabetes mellitus is an important consequence of distal 
pancreatectomy, ductal adenocarcinoma, chronic pancreatitis and a better understanding of the 
frequency and risk factors for this outcome may allow alteration of the treatment course. Our 
goal involves identifying causes and differences between some entities of type 3c diabetes 
mellitus    
Materials and methods.. The following represents a summary of the relevant literature in 
electronic databases, with the purpose of providing more insight into the important 
relationships between pancreatic ductal adenocarcinoma (PDAC), distal pancreatomy and 
chronic pancreatitis with diabetes. Relevant literature cited in electronic databases Scopus, 
EMBASE, MEDLINE, Web of Science, The Nature, The Lancet.   
Results. Even if in case of distal pancreatectomy etiology may be clear-absence of islets leads 
to lowering of the insulin, there are however some specifics: Due to an increased peripheral 
sensitivity to insulin and the reduced glucagon level in pancreatogenic diabetes, exogenous 
insulin administration frequently causes hypoglycemic attacks, characteristically called 
‘brittle’ diabetes. On the other side low levels of pancreatic polypeptide raises blood glucose 
level drastically. In chronic pancreatitis (CP) inflammatory environment and increased 
concentration of pro-inflammatory cytokines such interleukin 1β, 1R, tumor necrosis factor 
(TNF) α and agents like adrenomedullin or vanin-1 within the pancreatic parenchyma mediate 
β-cell dysfunction before frank β-cell loss. As chronic pancreatitis progresses, the extensive 
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fibrosis of the exocrine pancreas slowly destroys the pancreatic islet tissue. Moreover, 
deficiency of the Pancreatic polypeptide, which regulates the expression and availability of 
hepatic insulin receptors, leads to persistent hepatic glucose production that makes 
hyperglycemia more severe, fact that proves the observation that insulin resistance in CP 
appears to be independent of other components of the metabolic syndrome. On the other hand, 
in pancreatic ductal adenocarcinoma (DA), due to glandular destruction hypoinsulinemia 
would be expected, however, diabetes secondary to pancreatic cancer is associated with 
hyperinsulinaemia secondary to insulin resistance. This may be due to raised circulating level 
of islet amyloid polypeptide (IAPP), also known as amylin, which reduces insulin sensitivity 
in vivo and glycogen synthesis in vitro, that are found to be higher in patients with DA, 
although pancreatic tumors expressed neither IAPP nor insulin. It has been suggested that 
supernatant from cell lines of pancreatic ductal adenocarcinoma has been playing a key role in 
insulin modulation.   
Conclusions. Despite the potential resemblance to type 1 and type 2 diabetes, pancreatogenic 
diabetes has a unique structure of hormonal and metabolic characteristics; it is rated as unique 
clinical and metabolic unit. Clinical features are closely related to pathogenetic ones. Due to 
abnormal incretin response and cranky effect of PP and amylin the question of peripheral 
sensitivity to insulin, since it is closely related to the problem of antihyperglycemic therapy, is 
still open. The development and improvement of new technologies such as islet auto-
transplantation in liver, PP replacement, and artificial endocrine pancreas will help to provide 
better glycemic control in patients with type 3c diabetes.   
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Introduction. Despite all improvements in both surgical and other conservative therapies, 
pancreatic cancer is steadily associated with a poor overall prognosis and remains the fourth 
leading cause of cancer-related mortality in the world. About 80% of patients who have 
received a diagnosis of pancreatic cancer already have other organ metastasis, as well as local 
tumor in the late stage. Therefore, appropriate palliation for the main symptoms, such as 
obstructive jaundice, duodenal obstruction, and pain, is most important. The role of palliative 
surgery in locally advanced pancreatic cancer mainly involves patients who are found 
unresectable during open surgical exploration and consists of combined biliary and duodenal 
bypass procedures.  
Aim of the study. Analysis of clinical and paraclinical methods of diagnosis and  palliative 
surgical treatment of patients with cephalopancreatic cancer. 
Materials and methods. The current study presented 548 cases with malignant obstructive 
jaundice from the Gastrology Clinic of IMSP IO Chișinău, between 2007-2019. Excluded from 
this research were any patients who underwent  resection, had no obstructive jaundice at the 
